display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - triple negative
es-BC - TNBC - NA - all population
taxanes
paclitaxel
paclitaxel followed by doxorubicin plus cyclophosphamide ALEXANDRA/IMpassion-030

Study type: